Access to antiretroviral treatment has expanded rapidly in South Africa, making it the country in the world with the largest treatment program. As antiretroviral treatment coverage continues to rise in resource-constrained settings, effective community-based adherence support interventions are of central importance in ensuring the long-term sustainability of treatment. This paper reports the findings from a randomized control trial of a peer adherence and nutritional support program implemented in a public health care setting in South Africa's antiretroviral treatment program. The analysis assesses the impact of these peer adherence and nutritional support interventions on self-reported adherence, timeliness of clinic and hospital visits, and immunologic response to antiretroviral treatment. Peer adherence and nutritional support improved the timeliness of adults´ clinic and hospital visits for routine follow-up while on antiretroviral treatment. Peer adherence support impacted positively on immunologic response to antiretroviral treatment. Scale-up of effective and sustainable community-based, peer-driven adherence and nutritional support interventions should form part of the United Nations AIDS Treatment 2.0 strategy's community mobilization and health system strengthening pillar.
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Introduction
In view of the reduction in the cost of triple-drug therapy and the accumulating evidence of the feasibility and effectiveness of ART in slowing the progression of AIDS in poor countries (Havlir, 1998 , Lange et al, 2004 Zewdie, Lange and Kuritzkes, 2004) , the South African government in 2003 announced a "roll-out" plan for antiretroviral treatment (ART) via the public health sector.
South Africa faces the largest HIV burden in the world and currently has the largest ARV treatment program in the world. At present, the program provides treatment to three million people living with HIV and AIDS (PLWHA) (Nene, 2015) .
The potential benefits of ARV treatment to the individual patient are enormous (Lange et al, 2004; Sterne, et al, 2005) and improvements in the health status of infected individuals are likely to benefit their families' and their children's well-being (Bhargava, 2005) . The patient's better health will enable him or her to contribute more to household production and wage-earning activity and to enjoy more leisure activities and a healthy life. As a consequence of the patient's health, other household members whose time would have gone to care for the AIDS patient or to substitute for the patient's work can instead pursue higher gain activities, including schooling for the children, labor market participation for adults and leisure activities. However, in order to ensure that these benefits are realized, adherence to ARV treatment must be strict (Nachega et al, 2010) . As ART is extended to populations far larger than have ever been reached by ARV treatment programs in developed countries, adherence is likely to suffer and information on the socioeconomic and policy determinants of adherence in poor countries will be increasingly needed. The UNAIDS Treatment 2.0 strategy, moreover, envisages an expanded role for the mobilization of communities in treatment programs (pillar 5), including the use of lay health workers or treatment supporters to provide adherence support to ART patients (UNAIDS, 2011) , which furthermore may impact on two other pillars of the Treatment 2.0 strategy, namely reduction in costs and the strengthening of delivery systems (Torpey et al., 2008) .
Research synthesis of empirical studies on ARV adherence however paints a relatively gloomy
picture. An early synthesis of the effects of adherence interventions for ART concludes that more widely targeted interventions have relatively small effects, while only interventions targeting 3 patients with known or anticipated adherence problems show medium effects (Amico et al., 2006) .
A more recently completed systematic review, which compares the adherence benefits of directly observed versus self-administered ARV treatment moreover finds that directly observed therapy does not outperform self-administered treatment on viral suppression and a range of other adherence measures (Ford et al., 2009) , thus bearing out Liechty and Bangsberg's (2003) pessimism regarding the benefits of directly observed therapy programs for ARV treatment. Yet, another systematic review, which expands study selection criteria to include nonrandomized study designs, claims that directly observed therapy does outperform self-administered treatment on adherence, immunologic and virologic outcomes (Hart et al., 2010) . Two recently published studies not included in the former syntheses in turn do report statistically significant, positive impacts on adherence of directly observed therapy interventions (Babudieri et al., 2011; Berg et al., 2011) , the latter of which employs a randomized study design. To date, therefore, there appears to be no consensus that community-based adherence support provided through the likes of lay workers impacts positively on adherence and clinical response to ARV treatment.
This paper employs longitudinal, panel data from the Effective Aids Treatment and Support in the
Free State (FEATS) study to determine how a randomized peer-adherence and nutritional support intervention impact on various subjective and more objective measures of ARV treatment adherence. Section 2 describes the study design and data, while section 3 summarizes the methods employed in the statistical and econometric analyses. Section 4 presents the results, while section 5 concludes.
Methodology
The Effective Aids Treatment and Support in the Free State (FEATS) study, a prospective cohort study and experimental study with a combined group time-series, quasi-or field experiment and In the Zelen design subjects are only offered and provided with information regarding the treatment that they are assigned. The Zelen design is deemed appropriate given the fact that: blinding is not practicable or possible; the use of classical randomization and informed consent procedures significantly threatens internal validity; the interventions are highly attractive; the control group receives standard care; the study focuses on a clinically relevant objective(s) and offers important new insights (Kaptchuk, 2001; MacLehose et al, 2001; Rains & Penzien, 2005) . study comprised a peer adherence and nutritional support intervention. The trial is registered in South Africa [DOH-27-0907-2025] and with the United States' National Institutes of Health (NHI) [NCT00821366].
Experiment
The open enrollment into this prospective, experimental study was managed by ARV nurses employed at each of the 12 larger phase-I ART clinics in Free State province. Eligible ARV clients had to be adult (18+ years), had to have initiated ART in the past month, and had to reside in the local community where the particular clinic is based. ARV patient and patient households recruited into the study were randomly assigned to one of three groups: a control group receiving treatment and support provided in the existing program, a group that received bi-weekly visits by trained peer adherence supporters (PAS) and a group that received the bi weekly visits by the PAS adherence supporters and nutritional supplements (refer Figure 4) . The nutritional support consisted of two 400g cans of meatballs and spaghetti in tomato sauce per week. Each can contains (per 100 grams) 420 kJ of energy, 6.6 grams of protein, 9.9 grams of carbohydrates, 4.1 grams of fat, 29.9 mg of magnesium, 116.6 mg of phosphorous, and 1.6 mg of iron. In addition, the tomatoes are a good source of vitamin C.
Prior to follow-up, the peer adherence and nutritional interventions were implemented.
Approximately 60 peer adherence supporters were recruited in consultation with ART staff at the relevant clinic, in proportion to the number of FEATS study participants recruited at each facility.
To be considered, individuals had to have been on ARV treatment for ≥ 12 months, had at least a grade-10 certificate, and live within walking distance from the relevant clinic. Peer adherence reporters received 5-days of basic training in ART and adherence support from staff at the School of Nursing at the University of the Free State. Training focused on seven main themes: facts about HIV/AIDS, anti-retroviral therapy (ART), adherence supported needed by an ART client, nutrition, infection control at home, and using a health care team approach. On the 5 th day of training, peer adherence supporters' knowledge and practical skills was assessed by the trainers using an oral test and practical exercise.
5
Following the completion of training and assessment, peer adherence supporters were assigned eight FEATS study participants each, four in each intervention arm. An original randomization list was employed for this purpose, with an additional, rank-ordered list of reserve cases, per intervention group. During recruitment, PAS explained the intervention to each client and obtained written, informed consent from FEATS study participants who volunteered to partake in the experiment. As illustrated in Figure 5 , a relatively large proportion of patients randomized to the two treatment arms of the study (almost one-third) could not be traced and contacted to be offered the relevant intervention. As a result, one in four study participants recruited into the two experiments represented so-called reserve cases originally included in the control group. A small proportion only (6.1% or 22 cases) of contacted study participants refused the offered adherence and nutritional support, while due to logistical issues a small number of participants assigned to a treatment crossed over to the other treatment arm at implementation (13 cases or 3.9%). (For a detailed discussion of Figure 5 refer to the CONSORT statement.)
During the study, a brief survey instrument was used to collect key information from the 52 peer adherence supporters (PAS) working in the project at the time. (Initially, a total of 57 peer adherence supporters was recruited, trained and employed. By this time, five PAS had resigned due to not being able to fulfil their responsibilities, with patients being re-assigned to other PAS.)
The peer adherence supporters can be described as follows:
• Predominantly female (98%) -only one male PAS remains in the study reports and further discussions into a monthly progress report. Information in the monthly report was used to determine PAS payments for the subsequent month. For the study participants allocated to group C, the PAS were in addition delivering two cans of the food support at each visit.
By completion of the FEATS intervention at 18-months, a substantial proportion of FEATS study participants (39.8%) had dropped out of the treatment arms, probably due to a combination of fatigue among both participants and peer adherence supporters as well as the potential discontinuation of support in anticipation of the completion of the study. On aggregate, patients spent 13.8 months on the FEATS treatment. Patients in the peer adherence support only arm on average were in the intervention for longer that patients in the adherence and nutritional support arm (14.4 versus 13.1 months), a difference that is statistically significantly different (p=0.011). Figure 6 shows the survival functions for each of the two treatment arms. However, the difference in the survival functions, according to the log-rank test for equality of survivor functions, is not statistically significantly different (p=0.227). At the completion of the intervention, study participants were debriefed and asked to sign a formal termination of experimental intervention notice. ARV patients in the control group were provided with two month's stock of the canned food that the peer adherence and nutritional support intervention group received for the duration of the experimental intervention.
In the subsequent pages, patient-level data are used to investigate the impact of peer adherence and nutritional support on measures of ARV treatment adherence and success.
Data collection
Trained enumerators conducted structured, face-to-face baseline interviews with ART patients recruited into the study. Written, informed consent was obtained from study participants by the nursing personnel at the respective clinics (for ARV patients), as well as by the enumerator (for ARV patients and ARV patient/comparison households). A facility survey was also conducted, during which semi-structured interviews were conducted with health care providers at each study site.
At follow-up, enumerators again obtained written, informed consent from study participants. Two rounds of follow-up interviews were conducted with patients. The median time between consecutive interviews was 11.7 months [IQR 10.6-15.9 months]. A total of 1,588 interviews were conducted with 653 individual patients, 422 of whom were interviewed at both follow-ups. By the second and final round of follow-up interviews, 218 patients had been lost to follow-up, primarily due to mortality among study participants (42.4%) and unknown whereabouts (34.1%), which translates into an aggregate attrition rate of 33.6%. Of the 337 patients that consented to enrollment in the adherence and nutritional support interventions at the commencement of the intervention, 288 or 85.4% were interviewed at the first round of follow-up interview, whereas 175 or 86.2% of the 203 study participants that completed the full 18-months of FEATS treatment were interviewed at the second and final round of follow-up interviews.
On completion of the study clinical bio-markers and other additional patient information were obtained from paper and electronic files. Patients at baseline, when first recruited into the study, 2
The study also included a household survey component, with interviews being conducted with patient and comparison households, this to achieve various other objectives of the larger study (refer CONSORT statement).
consented that the research team access their clinic and hospital records to collect the latter information.
2.3
Socio-demographic and other characteristics of the study population were marginally, but statistically significantly younger than study participants interviewed in both rounds of follow-up interviews), socio-demographics did not differ statistically significantly across FEATS study participants that stayed in the study and those that were lost to follow-up, thus suggesting the absence of major attrition bias.
Methods
Adherence outcomes for study participants were measured as follows: a continuous and dichotomous version of the CASE index of self-reported adherence (Mannheimer et al.. 2006 ); a continuous, normalized index of self-reported adherence derived from five categorical variables on self-reported adherence using multiple correspondence analysis (MCA adherence index); a selfreported, dichotomous 0/1 variable for a missed clinic or hospital visit; and timeliness for scheduled clinic and hospital visits, which represents a more objective proxy of adherence than self-reported adherence (Blacher et al., 2010; Kunutsor et al., 2010) . Delays in clinic and hospital visits, used here to measure timeliness of visits, were calculated by subtracting the scheduled visit dates from the actual visit dates for consecutive clinic and hospital visits. The latter variable was also converted into a dichotomous variable indicating whether the patient arrived three or more days late for the particular visit (=1) or not (=0). Immunologic response to ARV treatment is measured using CD4 counts (cells per microliter). (In the case of timeliness of clinic and hospital 9 visits and CD4 counts, the data includes all outcomes observed between recruitment into the study and completion of the FEATS experiment. The advantage of the latter approach is that the statistical power of the analysis increases dramatically, because observations included in the analysis originates from patients' records and is therefore not dependent on a patient interview having been conducted with the said FEATS study participant.)
The analysis conducted in this study comprised the following: Firstly, we assess balance at baseline in adherence outcomes and other observable socio-demographic characteristics, by original intent-to-treat status and actual treatment arms (Tables 2-5 ). On the basis of this evidence, we reflect on the presence of potential selection bias. Secondly, we employ basic bivariate analysis to assess differences in our main outcomes, i.e. self-reported adherence outcome, timeliness of Figure 9 ). In each case, we control for basic sociodemographics and ARV treatment duration. Following suggestions by Angrist et al (1996) and Greenland (2000) , the original intent-to-treat status is used as instrument to adjust for selection bias in the fixed effects (FE) regression analysis, while in the random effects (RE) regression analysis the inverse Mills ratio is used to adjust for selection bias. To be deemed significant for the purposes of discussion, results need to be statistically significant at least at the 95% level (although results significant at a 90% level are reported).
Results
At baseline, age, sex, education, monthly income and pre-ART CD4 count, in terms of the intentto-treat comparison, did not differ significantly across treatment arms, as did all self-reported measures of adherence. However, differences in marital status are statistically significant when comparing the peer adherence support only and control groups. The peer adherence support only arm comprise a larger proportion of single adults compared to the control group.
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Timeliness of clinic and hospital visits at baseline does though differ statistically significantly across treatment arms. Delays in clinic and hospital visits for clients in the two treatment arms exceeded delays for the control group. More specifically, delays in clinic visits were significantly lower in the peer adherence support only arm, and delays in hospital visits significantly lower in the peer adherence and nutritional support arm. These differences possibly are the result of patient files not being available for data extraction for all study participants, which implies that outcomes are not missing in a non-random manner. Yet, balance does exist across treatment arms in selfreported adherence and most observable socio-demographic characteristics.
Tables 4-5, however, illustrate the presence of a clear selection bias into the treatment arms of the experiment. In the case of the arm for peer adherence support only, those with higher levels of education selected into treatment. According to our results, study participants who exhibited poorer adherence than those in the control group in terms of record-based timeliness of clinic and hospital visits selected themselves into the peer adherence and nutritional support interventions.
The opposite, however, is true for self-reports of missed clinic and/or hospital visits. Here, those selecting into the peer adherence support only arm, reported better adherence than in the control group. (As the former are considered more objective measures of adherence, we discount the latter evidence of selection bias in favor of the former.) For these reasons, regression results were adjusted for selection bias using instrumental variables (IV).
Moving to study outcomes as observed before and during the provision of peer adherence and nutritional support, there are few significant differences in adherence outcomes by the intent-totreat assignment of subjects. Only in the case of the proportion of delayed clinic visits is the outcome significantly better in the two treatment arms as well as in the combined treatment arm for any peer adherence support. The same is true for comparisons based on actual treatment assignment, including for the duration of delays in clinic visits (see Figures 7a/b ). This is not true for hospital visits (Figures 8a/b) .
The attention now shifts to the results of the regression analysis. Table 8 provides little evidence that the experiment's interventions impacted significantly on measures of self-reported adherence.
(Two of the three results significant at the 10% level are counter-intuitive (support increases the reporting of missed clinic and/or hospital visits), whereas one result only supports the argument that peer adherence and nutritional support results in fewer missed visits for routine medical checkups.) No results are statistically significant at the 5% level. after 1 month, 24 points higher after 4 months, 50 points higher after 16 months, and 60 points higher after 25 months. These significant improvements in CD4 counts are maintained across the duration of the peer adherence support intervention, regardless of whether adherence support commences at 6, 12 or 18 months on ARV treatment (Figure 9 ).
The result that nutritional support (in combination with peer adherence support) does not impact on clinical outcomes is perhaps not surprising, given the relatively small size of the supplement (2 cans of food per week) and the fact that the vast majority of clients (>95%) reported sharing the food with others. It is also likely that patients took up the combined treatment, not because of a need for peer adherence support, but due to the opportunity of receiving nutritional support that helps strengthen the household's food security.
It is also interesting here that the impacts of treatment on behavioral as opposed to biomedical outcomes are different: peer adherence and nutritional support impact on timeliness of visits, while peer adherence support only impacts on immunologic response. Further research is required to untangle the behavioral complexities underlying such results.
12

Conclusion
The quantitative findings presented in this paper suggest that peer adherence and nutritional support, though not impacting significantly on self-reported adherence, do improve the timeliness of adults´ clinic and hospital visits. In addition, adherence support has been shown to impact positively on immunologic response to ART treatment. These results suggest that scaled-up effective and sustainable community-based, peer-driven adherence and nutritional support interventions would be a useful component of the UNAIDS Treatment 2.0 strategy´s community mobilization and health systems strengthening pillars. represent the CD4 count observed closest to but prior to ARV treatment initiation. Some percentages may not add up to 100% across categories due to rounding. One, two and three asterisks denote differences that are statistically significant at the 10%, 5% and 1% levels, respectively.
Source: Authors' own calculations. 
